We directly assessed cell viability of untreated, RANKL- or prostate cancer CM-treated precursors, and have found that soluble factors secreted by prostate cancer cells enhanced monocyte viability (Figure 1D). The gene discussed is TNFSF11; the disease is Familial prostate cancer.